Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:209–49.

PubMed  Google Scholar 

WHO. Internation Agency for Research on Cancer. Lyon: WHO; 2023.

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53.

Article  CAS  PubMed  Google Scholar 

Velleuer E, Dietrich R. Fanconi anemia: young patients at high risk for squamous cell carcinoma. Mol Cell Pediatr. 2014;1:1–6.

Article  Google Scholar 

Georgy SR, Cangkrama M, Srivastava S, Partridge D, Auden A, Dworkin S, et al. Identification of a novel proto-oncogenic network in head and neck squamous cell carcinoma. J Natl Cancer Inst. 2015;107:djv152.

Article  PubMed  PubMed Central  Google Scholar 

Bai Y, Zhao Z, Boath J, van Denderen BJ, Darido C. The functional GRHL3-filaggrin axis maintains a tumor differentiation potential and influences drug sensitivity. Mol Ther. 2021;29:2571–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bai Y, Gotz C, Chincarini G, Zhao Z, Slaney C, Boath J, et al. YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells. Nat Commun. 2023;14:1591.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233:780–6.

Article  PubMed  PubMed Central  Google Scholar 

Louie KS, Mehanna H, Sasieni P. Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025. Oral Oncol. 2015;51:341–8.

Article  PubMed  Google Scholar 

Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41:660.

Article  PubMed  PubMed Central  Google Scholar 

de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8:e180–e90.

Article  PubMed  Google Scholar 

De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13:607–15.

Article  PubMed  Google Scholar 

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30:F12–F23.

Article  PubMed  Google Scholar 

Buchanan TR, Graybill WS, Pierce JY. Morbidity and mortality of vulvar and vaginal cancers: impact of 2-, 4-, and 9-valent HPV vaccines. Hum Vaccines Immunother. 2016;12:1352–6.

Article  Google Scholar 

Asiaf A, Ahmad ST, Mohammad SO, Zargar MA. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. Eur J Cancer Prev. 2014;23:206–24.

Article  CAS  PubMed  Google Scholar 

De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J cancer. 2017;141:664–70.

Article  PubMed  PubMed Central  Google Scholar 

Stein AP, Saha S, Kraninger JL, Swick AD, Yu M, Lambertg PF, et al. Prevalence of human papillomavirus in oropharyngeal cancer: a systematic review. Cancer J. 2015;21:138.

Article  PubMed  PubMed Central  Google Scholar 

Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012;6:104–20.

Article  PubMed Central  Google Scholar 

Michaud DS, Langevin SM, Eliot M, Nelson HH, Pawlita M, McClean MD, et al. High‐risk HPV types and head and neck cancer. Int J Cancer. 2014;135:1653–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim. 2020;6:92.

Article  PubMed  Google Scholar 

Yousefi Z, Aria H, Ghaedrahmati F, Bakhtiari T, Azizi M, Bastan R, et al. An update on human papilloma virus vaccines: history, types, protection, and efficacy. Front Immunol. 2022;12:6036.

Article  Google Scholar 

Rosenblum HG, Lewis RM, Gargano JW, Querec TD, Unger ER, Markowitz LE. Human papillomavirus vaccine impact and effectiveness through 12 years after vaccine introduction in the United States, 2003 to 2018. Ann Intern Med. 2022;175:918–26.

Article  PubMed  Google Scholar 

Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50.

Article  CAS  PubMed  Google Scholar 

Van Doorslaer K, Chen Z, Bernard H-U, Chan PK, DeSalle R, Dillner J, et al. ICTV virus taxonomy profile: papillomaviridae. J Gen Virol. 2018;99:989–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Urbanelli L, Buratta S, Tancini B, Sagini K, Delo F, Porcellati S, et al. The role of extracellular vesicles in viral infection and transmission. Vaccines. 2019;7:102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aydin I, Weber S, Snijder B, Samperio Ventayol P, Kühbacher A, Becker M, et al. Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog. 2014;10:e1004162.

Article  PubMed  PubMed Central  Google Scholar 

Zhang W, Kazakov T, Popa A, DiMaio D. Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity. MBio. 2014;5:e01777–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pol SBV, Klingelhutz AJ. Papillomavirus E6 oncoproteins. Virology. 2013;445:115–37.

Article  Google Scholar 

Roman A, Munger K. The papillomavirus E7 proteins. Virology. 2013;445:138–68.

Article  CAS  PubMed  Google Scholar 

Bharadwaj M, Hussain S, Tripathi R, Singh N, Mehrotra R. Human papillomavirus (HPV): diagnosis and treatment. In: Verma AS, Singh A, editors. Animal biotechnology. Amsterdam: Elsevier; 2014. p. 95–120.

Oh K-J, Kalinina A, Bagchi S. Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis. Virology. 2010;396:118–24.

Article  CAS  PubMed  Google Scholar 

O’Connor M, Chan S-Y, Bernard H-U. Transcription factor binding sites in the long control region of genital HPVs. Hum Papillomaviruses. 1995;21–40.

Li N, Lam WH, Zhai Y, Cheng J, Cheng E, Zhao Y, et al. Structure of the origin recognition complex bound to DNA replication origin. Nature. 2018;559:217–22.

Article  CAS  PubMed  Google Scholar 

Yu L, Majerciak V, Zheng Z-M. HPV16 and HPV18 genome structure, expression, and post-transcriptional regulation. Int J Mol Sci. 2022;23:4943.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology. 2015;4:e965570.

Article  PubMed  PubMed Central  Google Scholar 

Mandal R, Şenbabaoğlu Y, Desrichard A, Havel JJ, Dalin MG, Riaz N, et al. The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight. 2016;1:e89829.

Ward M, Thirdborough S, Mellows T, Riley C, Harris S, Suchak K, et al. Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer. 2014;110:489–500.

Article  CAS  PubMed  Google Scholar 

Canning M, Guo G, Yu M, Myint C, Groves MW, Byrd JK, et al. Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy. Front Cell Dev Biol. 2019;7:52.

Article  PubMed  PubMed Central  Google Scholar 

Costa NL, Valadares MC, Souza PPC, Mendonça EF, Oliveira JC, Silva TA, et al. Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma. Oral Oncol. 2013;49:216–23.

Article  CAS  PubMed  Google Scholar 

Ferris RL, Hunt JL, Ferrone S. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance. Immunol Res. 2005;33:113–33.

Article  CAS  PubMed  Google Scholar 

Ferris RL, Whiteside TL, Ferrone S. Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer. Clin Cancer Res. 2006;12:3890–5.

Article  CAS  PubMed